California State Teachers Retirement System (CalSTRS)’s Landos Biopharma, Inc. Common Stock LABP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-196
Closed -$3K 3388
2022
Q1
$3K Buy
196
+39
+25% +$992 ﹤0.01% 3204
2021
Q4
$8K Sell
157
-96
-38% -$10.1K ﹤0.01% 3240
2021
Q3
$37K Sell
253
-643
-72% -$83.5K ﹤0.01% 3131
2021
Q2
$103K Sell
896
-56
-6% -$6.24K ﹤0.01% 3042
2021
Q1
$92K Buy
+952
New +$124K ﹤0.01% 3052

Other funds holding LABP

California State Teachers Retirement System (CalSTRS)'s LABP Position: Q2 2022 in Review

California State Teachers Retirement System (CalSTRS) sold out of Landos Biopharma, Inc. Common Stock (LABP) in Q2 2022, closing a stake of 196 shares — an estimated $3K sold.

California State Teachers Retirement System (CalSTRS) first reported a position in LABP in Q1 2021 and held it in 5 quarters. The position peaked at $103K in Q2 2021. 34 funds tracked by Wall St. Rank hold LABP as of Q2 2022.

  • California State Teachers Retirement System (CalSTRS) reported no remaining Landos Biopharma, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • California State Teachers Retirement System (CalSTRS) sold 196 Landos Biopharma, Inc. Common Stock shares in Q2 2022, an estimated $3K.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Landos Biopharma, Inc. Common Stock in Q1 2021 and held it in 5 quarters.
  • California State Teachers Retirement System (CalSTRS)'s Landos Biopharma, Inc. Common Stock position peaked at $103K in Q2 2021.
  • 34 funds tracked by Wall St. Rank held Landos Biopharma, Inc. Common Stock as of Q2 2022.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2022, filed 15 Aug 2022.